Table 3 Baseline prior history and medication of the 455 patients with different apoE alleles
Total | Non-ε4 carriers | ε4 carriers | Odds-ratio (95% CI) | p-value | |
|---|---|---|---|---|---|
Prior history | |||||
Diabetes mellitus | 24.9% | 26.3% | 20.5% | 0.723 (0.398-1.313) | 0.285 |
Prior CHD | 4.2% | 4.9% | 2.4% | 0.478 (0.105 - 2.179) | 0.330 |
Current smoker | 21.2% | 22.4% | 17.1% | 0.712 (0.375 - 1.353) | 0.298 |
Alcohol consumption | 52.8% | 55.1% | 45.1% | 0.670 (0.408 - 1.101) | 0.112 |
Regular exercise | 10.6% | 11.2% | 8.4% | 0.728 (0.308 - 1.720) | 0.467 |
Use of a salty diet | 57.3% | 58.2% | 54.2% | 0.851 (0.519 - 1.395) | 0.522 |
Prior medication | |||||
Aspirin | 41.8% | 44.5% | 32.9% | 0.612 (0.357 - 1.048) | 0.072 |
Beta-blockers | 22.0% | 23.7% | 16.7% | 0.646 (0.325 - 1.284) | 0.210 |
ACEi | 33.3% | 36.4% | 23.0% | 0.522 (0.287 - 0.950) | 0.032 |
ARB | 21.3% | 21.9% | 19.2% | 0.817 (0.415 - 1.607) | 0.614 |
Calcium antagonist | 19.2% | 19.9% | 16.9% | 0.817 (0.415 - 1.607) | 0.557 |
Hypolipidemic drug* | 81.6% | 83.1% | 76.5% | 0.663 (0.344 - 1.277) | 0.217 |